Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in URGN — UroGen Pharma Ltd.

CIK 1603466 STAMFORD, CT
Back to URGN Full portfolio

Position in URGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$56,140,203
+$53,827,931 QoQ
Shares Held
1,525,549
+803.9% QoQ
Ownership
3.12%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#9
of 190 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. URGN ranks #12 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in URGN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $56,140,203 1,525,549
2025-06-30 $2,312,272 168,779
2025-03-31 $2,610,226 236,006
2024-12-31 $3,377,264 317,114
2024-09-30 $19,134,404 1,506,646
2024-06-30 $41,098,868 2,449,277
2024-03-31 $16,680,300 1,112,020
2023-12-31 $1,890,000 126,000
2023-09-30 $2,910,339 207,733